Emergency Preparedness and Response

MCMi Regulatory Science Symposium

FDA’s Medical Countermeasures Initiative (MCMi) sponsors an annual Regulatory Science Symposium to exchange ideas on MCM development, highlight work on regulatory science as it applies to developing and advancing MCMs, and informing stakeholders on MCM-related scientific progress and achievements.

2015 FDA Science Forum

In lieu of a separate MCMi Regulatory Science Symposium in 2015, MCMi regulatory science research will be discussed as part of the FDA Science Forum May 27-28, 2015 at FDA headquarters in Silver Spring, Maryland.

2014 MCMi Regulatory Science Symposium

4.3 A rapid, multiplexed, mobile phone-enabled point of care diagnostic device to detect Category A bioterror agents. Tam, J.; Yen, C.,; de Puig Guixe, H.; Miyazaki, H.; Fiegen, A.; Phillips, E.; Gomez-Marquez, J.; Hamad-Schifferli, K.; Bosch, I., Regan, P.; Clavet, C.; and Gehrke, L. FDA, Massachusetts Institute of Technology and Harvard Medical School.

Honorable mention: 5.1 Imaging Enterobacteriaceae Infection with Fluorodeoxysorbitol Positron Emission Tomography. Weinstein, E.; Ordonez, A.; DeMarco, V.; Murawski, A.; Pokkali, S.; MacDonald, E.; Klunk, M.; Mease, R.; Pomper, M.; and Jain, S. FDA CDER.

Honorable mention: 2.6  Development and Validation of Electroencephalographic (EEG) Biomarkers for Brain Injury Monitoring. Ye, M.; Fisher, J.; Nabili, M.; Huang, S.; Kim, Y.; Liu, Y.; Krauthamer, V.; Civillico, E.; Myers, M.; and Welle, C. FDA CDRH

 

2013 MCMi Regulatory Science Symposium

 

 2012 MCMi Regulatory Science Symposium

 

Page Last Updated: 03/20/2015
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.